Incyte INCY
NASDAQ INCY
$123.20 -1.62 (-1.30%)
At close: Sep 29, 2026 · 4:00 PM EDT

Incyte (INCY) Acquisitions (2016)

Updated

Incyte's Acquisitions came in at -$109,000 for Q4 2016.

Analysis

Incyte (INCY) Acquisitions (2016) Analysis & Trends

For FY2016, Incyte's Acquisitions was $142.86 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn -17.24 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -23.00 Mn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn -
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.21 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Incyte 25.09 Bn 10.02 Bn 1.57 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2016 -109,000.00
Sep 30, 2016 -1.88 Mn
API Access

Incyte Acquisitions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=acquisitions&ticker=INCY&period=max&api_key=YOUR_API_KEY